echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > CNNC Titanium Dioxide invested in the establishment of a new material company

    CNNC Titanium Dioxide invested in the establishment of a new material company

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 9, CNNC Titanium Dioxide announced that its wholly-owned subsidiary Gansu Dongfang Titanium Industry C.


    Zetong New Energy's business scope includes electronic special material manufacturing, emerging energy technology research and development, electronic special material research and development, new material technology research and development,et.


    CNNC Titanium Dioxide said that in order to further expand the development space, it will focus on the four business sectors of "resources, chemicals, new materials, and new energy", and actively explore and deploy new development opportunitie.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.